Agios Pharmaceuticals paid its 5 named executives $15.1M in total in FY2025 (Dec). CEO Brian Goff was paid $5.4M of that.
Pay$100 in the stock at the end of FY20 → $63
Pay of each named executive
Brian GoffChief Executive Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
Krishnan Viswanadhan, Pharm.DChief Corporate Development & Strategy Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | Not disclosed | ||||||
| FY2023 (Dec) | Not disclosed |
3 years
Cecilia JonesChief Financial Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
James BurnsChief Legal Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
Sarah GheuensChief Medical Officer, Head of Research & Development
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
CEO pay against the pay peers
In FY2025 (Dec), the median CEO pay of the 2 peers with pay on file was $10.9M. The CEO of Agios Pharmaceuticals was paid $5.4M, 51% below the median.
- 1Ultragenyx Pharmaceutical
- 2Mirum Pharmaceuticals
- 3Agios PharmaceuticalsThis company
- 4Acadia PharmaceuticalsNot disclosed
- 5Amicus Therapeutics, Inc.Not disclosed
- 6Apellis Pharmaceuticals, Inc.Not disclosed
- 7Arcus Biosciences, Inc.Not disclosed
- 8Biocryst PharmaceuticalsNot disclosed
- 9Blueprint Medicines CorporationNot disclosed
- 10Crinetics Pharmaceuticals, Inc.Not disclosed
- 11Intellia Therapeutics, Inc.Not disclosed
- 12Rhythm PharmaceuticalsNot disclosed
- 13Sage Therapeutics, Inc.Not disclosed
- 14SpringWorks Therapeutics, Inc.Not disclosed
- 15Travere Therapeutics, Inc.Not disclosed
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.